Literature DB >> 21526281

[Results of antimicrobial susceptibility surveillance in Chile: consolidating a network].

Francisco Silva O1, Marcela Cifuentes D, M Eugenia Pinto C.   

Abstract

Antimicrobial resistance is an increasing public health issue. Creation of surveillance networks is a matter of major importance for antimicrobial resistance understanding and monitoring. Also, they contribute to design actions for controlling its appearance and dissemination. In 2007 a colaborative group in antimicrobial resistance was formed, representing several health institutions across the country. In this paper we report the results of 2009 surveillance with emphasis in its interpretation, limitations and future perspectives.

Mesh:

Substances:

Year:  2011        PMID: 21526281     DOI: /S0716-10182011000100004

Source DB:  PubMed          Journal:  Rev Chilena Infectol        ISSN: 0716-1018            Impact factor:   0.520


  4 in total

Review 1.  Gram-negative infections in adult intensive care units of latin america and the Caribbean.

Authors:  Carlos M Luna; Eduardo Rodriguez-Noriega; Luis Bavestrello; Manuel Guzmán-Blanco
Journal:  Crit Care Res Pract       Date:  2014-11-27

Review 2.  Resistant gram-negative infections in the outpatient setting in Latin America.

Authors:  M J C Salles; J Zurita; C Mejía; M V Villegas
Journal:  Epidemiol Infect       Date:  2013-08-07       Impact factor: 2.451

3.  Bacteremic pneumococcal pneumonia: serotype distribution, antimicrobial susceptibility, severity scores, risk factors, and mortality in a single center in Chile.

Authors:  Alberto Fica; Nicolás Bunster; Felipe Aliaga; Felipe Olivares; Lorena Porte; Stephanie Braun; Jeannette Dabanch; Juan Carlos Hormázabal; Antonio Hernández; María Guacolda Benavides
Journal:  Braz J Infect Dis       Date:  2013-10-10       Impact factor: 3.257

Review 4.  Extended spectrum β-lactamase producers among nosocomial Enterobacteriaceae in Latin America.

Authors:  Manuel Guzmán-Blanco; Jaime A Labarca; Maria Virginia Villegas; Eduardo Gotuzzo
Journal:  Braz J Infect Dis       Date:  2014-01-03       Impact factor: 3.257

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.